IQ MPS 

CIVM designed to recapitulate organs most frequently impacted by off-target toxicity, such as liver and GI, and therapeutic targets that are difficult to model in vitro, such as lung, have received the greatest attention for their potential to improve clinical translatability. This module will provide a detailed overview of those CIVM models with which the field has the most experience. Each session will focus on a different organ system and utilize case studies to illustrate how pharmaceutical end users are applying these models for internal decision-making and the unique considerations and challenges for qualifying these models for each context of use.